Group 1 | Group 2 | Group 3 | F (ANOVA) or χ2 test statistic | P-value | |
---|---|---|---|---|---|
≤ 8 oocytes | 9–17 oocytes | ≥ 18 oocytes | |||
No. treatment cycles (n) | 4870 | 10,106 | 3296 | ||
Age (years), x̄ ± SD | 32.40 ± 5.20 | 30.09 ± 4.69 | 28.48 ± 4.16 | 724.77 | < 0.0001 |
BMI (kg/m2), x̄ ± SD | 22.06 ± 3.11 | 21.83 ± 3.02 | 21.74 ± 3.07 | 12.36 | < 0.0001 |
AFC, Median [IQR] | 9 [6,12] | 13 [10,17] | 16 [12,20] | 2252.7981 | < 0.0001 |
Total dose of gonadotropins (IU), Median [IQR] | 2,700 [2,025, 3,525] | 2,100 [1,537.5, 2,775] | 1,762.5 [1,350, 2,475] | 1685.9298 | < 0.0001 |
Duration of ovarian stimulation (days), x̄ ± SD | 11.35 ± 2.21 | 11.70 ± 2.10 | 12.22 ± 2.46 | 153 | < 0.0001 |
LH on hCG trigger day (IU/L), Median [IQR] | 0.93 [0.6,1.4] | 0.88 [0.57,1.36] | 0.79 [0.49,1.23] | 107.741 | < 0.0001 |
P on hCG trigger day (ng/mL), Median [IQR] | 0.658 [0.43, 0.89] | 0.82 [0.58, 1.07] | 0.98 [0.711, 1.28] | 1272.15 | < 0.0001 |
E2 on hCG trigger day (pg/mL), Median [IQR] | 1,214 [879.1, 1,670] | 2,184 [1,635, 2,913] | 3,478 [2,602.22, 4,608.5] | 6.943.40 | < 0.0001 |
Endometrial thickness on hCG trigger day (mm), Median [IQR] | 10.6 [9, 12.4] | 10.9 [9.4, 12.6] | 10.8 [9.2, 12.5] | 51.1977 | < 0.0001 |
Oocytes retrieved, x̄ ± SD | 6.05 ± 1.79 | 12.53 ± 2.47 | 22.27 ± 5.01 | 29,589.6 | < 0.0001 |
No. available embryos, Median [IQR] | 2 [1 3] | 3[2,4] | 5 [3,7] | 3742.67 | < 0.0001 |
No. fresh embryos transferred, x̄ ± SD | 1.80 ± 0.41 | 1.86 ± 0.35 | 1.64 ± 0.48 | 258.05 | < 0.0001 |
Time to live birth (days), x̄ ± SD | 320.96 ± 98.26 | 330.08 ± 266.13 | 383.77 ± 187.53 | 65.79 | < 0.0001 |
Cancellation rate with no available embryos, n (%) | 627/4,870 (12.87%) | 458/10,106 (4.53%) | 80/3,296 (2.43%) | 488.223 | < 0.0001 |
Cycle cancellation for high risk of OHSS, n (%) | 14/4,870 (0.29%) | 305/10,106 (3.02%) | 782/3,296 (23.73%) | 2268.21 | < 0.0001 |
Moderate-to-severe OHSS rate, n (%) | 4/4,870 (0.08%) | 211/10,106 (2.09%) | 112/3,296 (3.4%) | 134.413 | < 0.0001 |
CLBR/cycle started, n (%) | 2,314/4,870 (47.52%) | 7,143/10,106 (70.68%) | 2,717/3,296 (82.43%) | 1244.99 | < 0.0001 |
No. fresh transfer cycles (n) | 4057 | 8878 | 1922 | ||
No. embryos transferred | 504.44 | < 0.0001 | |||
1 | 826/4057(20.36%) | 1240/8878(13.97%) | 685/1922(35.64%) | ||
2 | 3231/4057(79.64%) | 7638/8878(86.03%) | 1237/1922(64.36%) | ||
Embryo transfer type | 1610.83 | < 0.0001 | |||
Cleavage embryo | 3933/4057(96.94%) | 8296/8878(93.44%) | 1283/1922(66.75%) | ||
Blastocyst | 124/4057(3.06%) | 582/8878(6.56%) | 639/1922(33.25%) | ||
HCG positive rate | 2713/4057(66.87%) | 6889/8878(77.6%) | 1561/1922(81.22%) | 215.12 | < 0.0001 |
Clinical pregnancy rate | 2431/4057(59.92%) | 6378/8878(71.84%) | 1470/1922(76.48%) | 240.7 | < 0.0001 |
Abortion rate | 347/2431(14.27%) | 557/6378(8.73%) | 92/1470(6.26%) | 84.83 | < 0.0001 |
Live birth rate | 2044/4057(50.38%) | 5743/8878(64.69%) | 1361/1922(70.81%) | 320.48 | < 0.0001 |